20
KIT
Kit update and overview
This is a fairly fast and furious overview of various bits
of kit. Some are updates on currently available kit,
others are in development. Much is also only currently
relevant to the US, as indicated. By Sue Marshall
Beta Bionics
Beta Bionics, which has a small but
secure user base in the US on its
iLet pump system, expects to launch
a new insulin patch pump system
in the US by the end of 2027, as
reported by Drug Delivery Business.
The company revealed the new
'Mint' system in a live demonstration
at this year's American Diabetes
Association's conference (ADA),
outlining its plan for an eventual
launch within the next couple of
years. The company had already
announced that it planned to develop
a patch pump device that could rival
existing competitors as well as a
potential timeline to market.
The device's starter kit includes
a reusable Mint controller and a
month-long supply of disposable
insulin cartridges. It doesn't feature
a rechargeable component, as the
controller is expected to last around
two years. The cartridge has a
200-unit capacity and a disposable
battery. Bluetooth pairing is only
required at initiation and users don't
need their phone to conduct a patch
pump change. They only have to
remove the old cartridge, fill a new
one and reattach it to the controller.
Beta Bionics said users can control
Mint from its existing iLet app, and it
will be compatible with the Dexcom
G7 and Abbott FreeStyle Libre 3 Plus
sensors. Just in the US.
www.betabionics.com
Dexcom
Dexcom G7 now connects to
Omnipod 5 so that now Dexcom G7
and Dexcom G6 can connect with
Omnipod 5. Meanwhile, Dexcom
ONE+ which does not connect with
Omnipod 5. Dexcom ONE will be
removed from drug tariff on the 31st
March 2026.
The new and improved Dexcom
ONE+ was launched in June 2024
and supersedes Dexcom ONE. It
has fewer components - there is no
separate transmitter, so it's easier to
get started, 60% smaller sensor size
and a faster warm-up time of just
30 minutes. Anyone using receivers
will require a new Dexcom ONE+
compatible receiver.
Those who use the Omnipod
5 and Dexcom G7 CGM can now
manage the automated insulin
delivery system with their iPhones.
This new app update means people
with diabetes have one less device to
keep track of and carry (the Omnipod
PDM, or personal diabetes manager).
Now with G7 support, Omnipod 5
users can manage their diabetes
all with their iPhone. Once a pod is
attached to the body, the algorithm
runs from the pump itself, adjusting
insulin doses based on glucose levels.
Insulet had previously added support
for Android and Dexcom G6 users
who wanted to use their phones to
run the system. Just in the US.
www.dexcom.com
Glucotrack
In recent years, continuous glucose
monitoring devices (CGMs) have
revolutionized diabetes management,
offering numerous advantages over
ABOVE: Beta Bionic's proposed
Mint patch pump